Study Examines Trade-offs Between Label Resolution and Computational Cost in Lipid Metabolism Models
Researchers have identified that modelling three out of five isotopic labels in multi-label mass-spectrometry experiments provides an optimal balance between accuracy and computational cost for studying lipid metabolism. Multi-label strategies were developed to extract temporal information from single destructive measurements, but the computational burden grows rapidly with each additional label. The findings offer practical guidance for researchers designing experiments and computational models in lipid metabolism research.
A preprint posted to arXiv examines a fundamental trade-off in the computational modelling of lipid metabolism: as more isotopic labels are included in mass-spectrometry-based experiments, inferential power increases but so does computational complexity. Using synthetic data generated from a five-label experimental setup, the authors tested how different numbers of modelled labels affect parameter estimation accuracy, trajectory recovery, and processing cost. They found that modelling three of the five available labels strikes a practical balance across all three criteria. Critically, the study also demonstrates that the most computationally efficient approach—a single-label model—can produce biologically implausible predictions for species that are not directly observed, a risk that is mitigated when more labels are included. Applied to hepatocyte triglyceride cycling, the multi-label models better constrained the dynamics of these latent biological processes. The results provide a quantitative framework to help researchers choose an appropriate model resolution for their specific experimental and computational constraints.
What's missing
The study relies on synthetic data for its primary benchmarking; validation against real multi-label experimental datasets beyond the hepatocyte triglyceride cycling application is not reported. The generalizability of the three-label recommendation to lipid systems with different kinetic complexity or different numbers of available labels remains an open question.
What different sources said
- arXiv q-bioCenter
Balancing label resolution and computational cost in dynamical models of lipid metabolism
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.